UNSPSC 51151620: Benactyzine

This classification denotes an anticholinergic agent with the molecular formula C20H25NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 595EG71R3F, chemically known as ethanol, 2-(diethylamino)-, benzilate hydrochloride but generally known as benactyzine, which bears US NIH Compound Identifier 9330. benactyzine most often comes in base, chloride, hydrochloride, or methyl bromide forms. European Medicines Agency schedules Benactyzine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05696MIG.

UNSPSC 51151620 Benactyzine, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal pharmaceutical scope. The two most recent opportunities tagged to this code—Seminole County, Florida's IFB for naloxone and drug deactivation systems and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs—address naloxone procurement and pharmacy benefit management rather than benactyzine specifically. State and local buyers soliciting under this code are primarily county health departments and state HHS agencies focused on opioid-response initiatives and pharmacy program redesign. The actual work being purchased diverges significantly from the code's specific drug designation, suggesting either systematic miscoding in state procurement databases or that benactyzine itself sees no current demand in state and local markets.

Geographic activity centers on Florida and Texas based on the recent postings. Seminole County's IFB (posted June 30, 2026, due July 26, 2023) sought 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to Sanford, Florida, on a fixed-fee basis with two-year initial term and one-year renewal option. The Texas HHS Commission's RFI (posted April 3, 2026) gathered preliminary vendor input on direct-to-manufacturer prescription fulfillment but did not request benactyzine or propose formal competitive solicitation mechanics. No other state or local opportunities under this code appear in the recent record. Firms considering this code should verify whether their benactyzine products or services align with actual state and local demand signals, as current tagging suggests procurement systems may be capturing related pharmaceutical and pharmacy services rather than benactyzine procurement specifically.